Ijzermans JN - Search Results

1

Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.

Sewgobind VD, van der Laan LJ, Kho MM, Kraaijeveld R, Korevaar SS, van Dam T, Ijzermans JN, Weimar W, Baan CC. Sewgobind VD, et al. Among authors: ijzermans jn. Transplantation. 2010 Mar 27;89(6):655-66. doi: 10.1097/TP.0b013e3181c9cc7a. Transplantation. 2010. PMID: 20164820

2

Increase of major histocompatibility complex class II--positive cells in cardiac allografts by interferon-gamma has no impact on graft survival.

Ijzermans JN, Bouwman E, van der Meide PH, Jeekel J, Marquet RL. Ijzermans JN, et al. Transplantation. 1989 Dec;48(6):1039-41. doi: 10.1097/00007890-198912000-00029. Transplantation. 1989. PMID: 2512699

3

The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.

Ijzermans JN, Singh SK, de Bruin RW, Bouwman E, Weimar W, Marquet RL, Jeekel J. Ijzermans JN, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1385-6. Transplant Proc. 1987. PMID: 3274337 No abstract available.

4

Cells involved in rejection of rat heart allografts.

Bouwman E, Ijzermans JN, de Bruin RW, Heineman E, Marquet RL, Jeekel J. Bouwman E, et al. Among authors: ijzermans jn. Transplant Proc. 1987 Oct;19(5):4347-8. Transplant Proc. 1987. PMID: 3314040 No abstract available.

5

Successful treatment of Kaposi's sarcoma in a renal allograft recipient.

Marsman WA, Van Gelder T, Mulder AH, Ijzermans JN, Zietse R, Weimar W. Marsman WA, et al. Among authors: ijzermans jn. Nephrol Dial Transplant. 1995;10(6):900-1. Nephrol Dial Transplant. 1995. PMID: 7566628 No abstract available.

6

Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients.

Zietse R, van Ierland-van Leeuwen ML, Derkx FH, Ijzermans JN, Schalekamp MA, Weimar W. Zietse R, et al. Among authors: ijzermans jn. Am J Kidney Dis. 1994 Dec;24(6):927-31. doi: 10.1016/s0272-6386(12)81063-8. Am J Kidney Dis. 1994. PMID: 7985671

7

Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat.

Geerling RA, de Bruin RW, Scheringa M, Bonthuis F, Jeekel J, Ijzermans JN, Marquet RL. Geerling RA, et al. Among authors: ijzermans jn. Transplantation. 1994 Dec 15;58(11):1258-63. Transplantation. 1994. PMID: 7992371

8

Effect of isradipine on cyclosporin A-related hypertension.

van den Dorpel MA, Zietse R, Ijzermans JN, Schalekamp MA, Weimar W. van den Dorpel MA, et al. Among authors: ijzermans jn. Blood Press Suppl. 1994;1:50-3. Blood Press Suppl. 1994. PMID: 8205301 Clinical Trial.

9

Single-shot, high-dose rabbit ATG for rejection prophylaxis after kidney transplantation.

Zietse R, van Steenberge EP, Hesse CJ, Vaessen LB, IJzermans JN, Weimar W. Zietse R, et al. Among authors: ijzermans jn. Transpl Int. 1993;6(6):337-40. doi: 10.1007/BF00335971. Transpl Int. 1993. PMID: 8297463

10

Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine.

Scheringa M, Schraa EO, Bouwman E, van Dijk H, Melief MJ, Ijzermans JN, Marquet RL. Scheringa M, et al. Among authors: ijzermans jn. Transplantation. 1995 Dec 15;60(11):1350-3. Transplantation. 1995. PMID: 8525534 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

721 results

Search Page

Filters